163 related articles for article (PubMed ID: 19010852)
1. Diabodies targeting epithelial membrane protein 2 reduce tumorigenicity of human endometrial cancer cell lines.
Shimazaki K; Lepin EJ; Wei B; Nagy AK; Coulam CP; Mareninov S; Fu M; Wu AM; Marks JD; Braun J; Gordon LK; Wadehra M
Clin Cancer Res; 2008 Nov; 14(22):7367-77. PubMed ID: 19010852
[TBL] [Abstract][Full Text] [Related]
2. Epithelial membrane protein-2 is a novel therapeutic target in ovarian cancer.
Fu M; Maresh EL; Soslow RA; Alavi M; Mah V; Zhou Q; Iasonos A; Goodglick L; Gordon LK; Braun J; Wadehra M
Clin Cancer Res; 2010 Aug; 16(15):3954-63. PubMed ID: 20670949
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography imaging of endometrial cancer using engineered anti-EMP2 antibody fragments.
Fu M; Brewer S; Olafsen T; Wu AM; Gordon LK; Said J; Braun J; Wadehra M
Mol Imaging Biol; 2013 Feb; 15(1):68-78. PubMed ID: 22585360
[TBL] [Abstract][Full Text] [Related]
4. EMP2 is a novel therapeutic target for endometrial cancer stem cells.
Kiyohara MH; Dillard C; Tsui J; Kim SR; Lu J; Sachdev D; Goodglick L; Tong M; Torous VF; Aryasomayajula C; Wang W; Najafzadeh P; Gordon LK; Braun J; McDermott S; Wicha MS; Wadehra M
Oncogene; 2017 Oct; 36(42):5793-5807. PubMed ID: 28604744
[TBL] [Abstract][Full Text] [Related]
5. EMP2 regulates angiogenesis in endometrial cancer cells through induction of VEGF.
Gordon LK; Kiyohara M; Fu M; Braun J; Dhawan P; Chan A; Goodglick L; Wadehra M
Oncogene; 2013 Nov; 32(46):5369-76. PubMed ID: 23334331
[TBL] [Abstract][Full Text] [Related]
6. Rationale and preclinical efficacy of a novel anti-EMP2 antibody for the treatment of invasive breast cancer.
Fu M; Maresh EL; Helguera GF; Kiyohara M; Qin Y; Ashki N; Daniels-Wells TR; Aziz N; Gordon LK; Braun J; Elshimali Y; Soslow RA; Penichet ML; Goodglick L; Wadehra M
Mol Cancer Ther; 2014 Apr; 13(4):902-15. PubMed ID: 24448822
[TBL] [Abstract][Full Text] [Related]
7. Expression of epithelial membrane protein-2 is associated with endometrial adenocarcinoma of unfavorable outcome.
Wadehra M; Natarajan S; Seligson DB; Williams CJ; Hummer AJ; Hedvat C; Braun J; Soslow RA
Cancer; 2006 Jul; 107(1):90-8. PubMed ID: 16736513
[TBL] [Abstract][Full Text] [Related]
8. Epithelial membrane protein-2 promotes endometrial tumor formation through activation of FAK and Src.
Fu M; Rao R; Sudhakar D; Hogue CP; Rutta Z; Morales S; Gordon LK; Braun J; Goodglick L; Wadehra M
PLoS One; 2011; 6(5):e19945. PubMed ID: 21637765
[TBL] [Abstract][Full Text] [Related]
9. Steroid hormone regulation of EMP2 expression and localization in the endometrium.
Wadehra M; Mainigi M; Morales SA; Rao RG; Gordon LK; Williams CJ; Braun J
Reprod Biol Endocrinol; 2008 Apr; 6():15. PubMed ID: 18400107
[TBL] [Abstract][Full Text] [Related]
10. Epithelial membrane protein-2 expression is an early predictor of endometrial cancer development.
Habeeb O; Goodglick L; Soslow RA; Rao RG; Gordon LK; Schirripa O; Horvath S; Braun J; Seligson DB; Wadehra M
Cancer; 2010 Oct; 116(20):4718-26. PubMed ID: 20578181
[TBL] [Abstract][Full Text] [Related]
11. Epithelial membrane protein-2 (EMP2) promotes angiogenesis in glioblastoma multiforme.
Qin Y; Takahashi M; Sheets K; Soto H; Tsui J; Pelargos P; Antonios JP; Kasahara N; Yang I; Prins RM; Braun J; Gordon LK; Wadehra M
J Neurooncol; 2017 Aug; 134(1):29-40. PubMed ID: 28597184
[TBL] [Abstract][Full Text] [Related]
12. 89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors.
Chan AM; Olafsen T; Tsui J; Salazar FB; Aguirre B; Zettlitz KA; Condro M; Wu AM; Braun J; Gordon LK; Ashki N; Whitelegge J; Xu S; Ikotun O; Lee JT; Wadehra M
Mol Cancer Ther; 2024 Jun; 23(6):890-903. PubMed ID: 38417138
[TBL] [Abstract][Full Text] [Related]
13. Anti-EMP2 diabody blocks epithelial membrane protein 2 (EMP2) and FAK mediated collagen gel contraction in ARPE-19 cells.
Morales SA; Telander DG; Mareninov S; Nagy A; Wadehra M; Braun J; Gordon LK
Exp Eye Res; 2012 Sep; 102():10-6. PubMed ID: 22728127
[TBL] [Abstract][Full Text] [Related]
14. Epithelial membrane protein 2, a 4-transmembrane protein that suppresses B-cell lymphoma tumorigenicity.
Wang CX; Wadehra M; Fisk BC; Goodglick L; Braun J
Blood; 2001 Jun; 97(12):3890-5. PubMed ID: 11389031
[TBL] [Abstract][Full Text] [Related]
15. Targeting Interleukin-11 Receptor-α Impairs Human Endometrial Cancer Cell Proliferation and Invasion In Vitro and Reduces Tumor Growth and Metastasis In Vivo.
Winship AL; Van Sinderen M; Donoghue J; Rainczuk K; Dimitriadis E
Mol Cancer Ther; 2016 Apr; 15(4):720-30. PubMed ID: 26846819
[TBL] [Abstract][Full Text] [Related]
16. The antitumor effect of lobaplatin against Ishikawa endometrial cancer cells in vitro and in vivo.
He J; Zhang H
Biomed Pharmacother; 2019 Jun; 114():108762. PubMed ID: 30925454
[TBL] [Abstract][Full Text] [Related]
17. Epithelial membrane protein-2 (EMP2) activates Src protein and is a novel therapeutic target for glioblastoma.
Qin Y; Fu M; Takahashi M; Iwanami A; Kuga D; Rao RG; Sudhakar D; Huang T; Kiyohara M; Torres K; Dillard C; Inagaki A; Kasahara N; Goodglick L; Braun J; Mischel PS; Gordon LK; Wadehra M
J Biol Chem; 2014 May; 289(20):13974-85. PubMed ID: 24644285
[TBL] [Abstract][Full Text] [Related]
18. Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines.
Gentilin E; Minoia M; Bondanelli M; Tagliati F; Degli Uberti EC; Zatelli MC
Endocrine; 2017 Jun; 56(3):621-632. PubMed ID: 27585662
[TBL] [Abstract][Full Text] [Related]
19. Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents.
Eilon GF; Gu J; Slater LM; Hara K; Jacobs JW
Cancer Chemother Pharmacol; 2000; 45(3):183-91. PubMed ID: 10663635
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]